AssetMark’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
AssetMark's ANIP Position: Q3 2026 in Review
AssetMark increased its ANI Pharmaceuticals (ANIP) stake by 55% in Q3 2026, buying an estimated $462 and bringing the position to 17 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3186.
AssetMark first reported a position in ANIP in Q4 2017 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- AssetMark held 17 shares of ANI Pharmaceuticals worth $1.24K as of Q3 2026.
- AssetMark bought 6 ANI Pharmaceuticals shares in Q3 2026, an estimated $462.
- ANI Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3186 holding.
- AssetMark first reported a position in ANI Pharmaceuticals in Q4 2017 and has held it in 4 quarters since.
- 216 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.